Literature DB >> 13505801

Serum properdin levels and cancer cell homografts in man.

C M SOUTHAM, L PILLEMER.   

Abstract

Entities:  

Keywords:  NEOPLASMS/blood in; PROPERDIN/physiology

Mesh：

Substances：

Year:  1957        PMID： 13505801     DOI： 10.3181/00379727-96-23550

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  8 in total

1.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

2.  [Methodical and clinical research on the properdin system. II. Research on the behavior of the serum properdin and the C'3 components after gynecological operations].

Authors:  G SCHUMACHER; E EL HABASH; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

3.  [Methodical and clinical research on the properdin system. I. Methodical research on the simplified properdin test according to Isliker].

Authors:  G SCHUMACHER; F KNIERIM; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

4.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11

5.  Potentialities of surgery.

Authors:  W H COLE
Journal:  Ann Surg       Date:  1960-09       Impact factor: 12.969

6.  Comparative studies on the properdine level in the blood of two groups of students of moderate and increased muscular activity.

Authors:  W Romanowski; A Eberhardt; S Jasser
Journal:  Int Z Angew Physiol       Date:  1966-09-12

7.  The heterocytotoxicity of human serum. III. Studies of the serum levels and distribution of activity in human populations.

Authors:  G Glumac; A Mates; D Eidinger
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  The incidence of allergic disorders and cancer.

Authors:  W D Mackay
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.